These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8923565)

  • 41. The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects.
    Jiang ZP; Shu Y; Chen XP; Huang SL; Zhu RH; Wang W; He N; Zhou HH
    Eur J Clin Pharmacol; 2002 May; 58(2):109-13. PubMed ID: 12012142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the CYP2C19 genotype and cigarette smoking on the single oral dose pharmacokinetics and pharmacodynamics of estazolam.
    Aoshima T; Fukasawa T; Otsuji Y; Okuyama N; Gerstenberg G; Miura M; Ohkubo T; Sugawara K; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):535-8. PubMed ID: 12691790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia.
    Inomata S; Nagashima A; Itagaki F; Homma M; Nishimura M; Osaka Y; Okuyama K; Tanaka E; Nakamura T; Kohda Y; Naito S; Miyabe M; Toyooka H
    Clin Pharmacol Ther; 2005 Dec; 78(6):647-55. PubMed ID: 16338280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diazepam-cimetidine drug interaction: a clinically significant effect.
    Ruffalo RL; Thompson JF; Segal JL
    South Med J; 1981 Sep; 74(9):1075-8. PubMed ID: 6116285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zotepine for schizophrenia.
    Fenton M; Morris S; De-Silva P; Bagnall A; Cooper SJ; Gammelin G; Leitner M
    Cochrane Database Syst Rev; 2000; (2):CD001948. PubMed ID: 10796671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo.
    Rowley HL; Needham PL; Kilpatrick IC; Heal DJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):187-92. PubMed ID: 10685875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapeutic and adverse effects of zotepine and their relationships with serum kinetics of the drug].
    Ishida M
    Yakubutsu Seishin Kodo; 1993 Jun; 13(3):97-105. PubMed ID: 8237138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and neuroendocrine effects of zotepine--a new neuroleptic drug.
    von Bardeleben U; Benkert O; Holsboer F
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):28-34. PubMed ID: 2883678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H; von Bardeleben U; Holsboer F; Benkert O
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects.
    Bramness JG; Skurtveit S; Gulliksen M; Breilid H; Steen VM; Mørland J
    Eur J Clin Pharmacol; 2005 Aug; 61(7):499-506. PubMed ID: 16021435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
    Okamura N; Hashimoto K; Kanahara N; Shimizu E; Kumakiri C; Komatsu N; Iyo M
    Eur J Pharmacol; 2003 Feb; 461(2-3):93-8. PubMed ID: 12586203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance.
    Okada Y; Seo T; Ishitsu T; Wanibuchi A; Hashimoto N; Higa Y; Nakagawa K
    Ther Drug Monit; 2008 Aug; 30(4):540-3. PubMed ID: 18641551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectivity of zotepine in refractory psychoses: possible relationship between zotepine and non-dopamine psychosis.
    Harada T; Otsuki S; Sato M; Wake A; Fujiwara Y; Kashihara K; Fukuda K
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):47-51. PubMed ID: 2883682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia.
    Cooper SJ; Butler A; Tweed J; Welch C; Raniwalla J
    Psychopharmacology (Berl); 2000 Jun; 150(3):237-43. PubMed ID: 10923750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells.
    Yoshimura R; Shinkai K; Toyohira Y; Ueno S; Yanagihara N; Nakamura J
    Hum Psychopharmacol; 2005 Oct; 20(7):477-84. PubMed ID: 16158449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19.
    Cho JY; Yu KS; Jang IJ; Yang BH; Shin SG; Yim DS
    Br J Clin Pharmacol; 2002 Apr; 53(4):393-7. PubMed ID: 11966672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of zotepine on excitatory synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits.
    Kubota T; Jibiki I; Kurokawa S
    Eur J Pharmacol; 2002 Oct; 453(2-3):245-50. PubMed ID: 12398911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.
    Chung H; Lee H; Han HK; An H; Lim KS; Lee YJ; Cho JY; Yoon SH; Jang IJ; Yu KS
    Drug Des Devel Ther; 2015; 9():2609-16. PubMed ID: 25999694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.